Mechanistically, lncRNA-SLCC1 forms a complex with AHR to transcriptionally activate the glycolysis-promoting enzyme HK2, thereby driving glycolytic metabolism and accelerating CRC tumor growth (Fig. 2A) [20]. This evidence concerns the gene HK2 and neoplasm.